<DOC>
	<DOC>NCT00190866</DOC>
	<brief_summary>To assess the efficacy of Duloxetine compared with placebo in the treatment of pain in patients with Fibromyalgia syndrome, with or without major depressive disorder.</brief_summary>
	<brief_title>Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Meet criteria for primary Fibromyalgia Syndrome as defined by the American College of Rheumatology Have any current primary Axis I diagnosis other than major depressive disorder Have any current or previous diagnosis of psychosis, bipolar disorder, or schizoaffective disorder Have any primary diagnosis of anxiety disorder within the past year (including panic disorder, agoraphobia, OCD, PTSD, GAD and social phobia) Have regional pain syndrome, multiple surgeries or failed back syndrome Have a confirmed current or previous diagnosis of rheumatoid arthritis, inflammatory arthritis, or infective arthritis, or an autoimmune disease (e.g. lupus)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>